Poor Prognosis Patients with Inoperable Locally Advanced NSCLC and Large Tumors Benefit from Palliative Chemoradiotherapy: A Subset Analysis from a Randomized Clinical Phase III Tr...

por Strøm, Hans H., Bremnes, Roy M., Sundstrøm, Stein H., Helbekkmo, Nina, Aasebø, Ulf
Publicado 2014

High expression of microRNA-126 relates to favorable prognosis for colon cancer patients

por Selven, Hallgeir, Busund, Lill-Tove Rasmussen, Andersen, Sigve, Bremnes, Roy M., Kilvær, Thomas Karsten
Publicado 2021

Stage and tissue-specific prognostic impact of miR-182 in NSCLC

por Stenvold, Helge, Donnem, Tom, Andersen, Sigve, Al-Saad, Samer, Busund, Lill-Tove, Bremnes, Roy M
Publicado 2014

Profiling of VEGFs and VEGFRs as Prognostic Factors in Soft Tissue Sarcoma: VEGFR-3 Is an Independent Predictor of Poor Prognosis

por Kilvaer, Thomas K., Valkov, Andrej, Sorbye, Sveinung, Smeland, Eivind, Bremnes, Roy M., Busund, Lill-Tove, Donnem, Tom
Publicado 2010

The Prognostic Impact of TGF-β1, Fascin, NF-κB and PKC-ζ Expression in Soft Tissue Sarcomas

por Valkov, Andrej, Sorbye, Sveinung W., Kilvaer, Thomas K., Donnem, Tom, Smeland, Eivind, Bremnes, Roy M., Busund, Lill-Tove
Publicado 2011

Prognostic Impacts of Angiopoietins in NSCLC Tumor Cells and Stroma: VEGF-A Impact Is Strongly Associated with Ang-2

por Andersen, Sigve, Donnem, Tom, Al-Shibli, Khalid, Al-Saad, Samer, Stenvold, Helge, Busund, Lill-Tove, Bremnes, Roy M.
Publicado 2011

Fibroblast growth factor 2 orchestrates angiogenic networking in non-GIST STS patients

por Kilvaer, Thomas K, Valkov, Andrej, Sorbye , Sveinung W, Smeland, Eivind, Bremnes, Roy M, Busund, Lill-Tove, Donnem, Tom
Publicado 2011

Overexpression of the HIF Hydroxylases PHD1, PHD2, PHD3 and FIH Are Individually and Collectively Unfavorable Prognosticators for NSCLC Survival

por Andersen, Sigve, Donnem, Tom, Stenvold, Helge, Al-Saad, Samer, Al-Shibli, Khalid, Busund, Lill-Tove, Bremnes, Roy M.
Publicado 2011

The prognostic impact of Akt isoforms, PI3K and PTEN related to female steroid hormone receptors in soft tissue sarcomas

por Valkov, Andrej, Kilvaer, Thomas K, Sorbye, Sveinung W, Donnem, Tom, Smeland, Eivind, Bremnes, Roy M, Busund, Lill-Tove
Publicado 2011

The VEGF- and PDGF-family of angiogenic markers have prognostic impact in soft tissue sarcomas arising in the extremities and trunk

por Kilvaer, Thomas K, Smeland, Eivind, Valkov, Andrej, Sorbye, Sveinung W, Bremnes, Roy M, Busund, Lill-Tove, Donnem, Tom
Publicado 2014

Prognostic Impacts of Hypoxic Markers in Soft Tissue Sarcoma

por Smeland, Eivind, Kilvaer, Thomas K., Sorbye, Sveinung, Valkov, Andrej, Andersen, Sigve, Bremnes, Roy M., Busund, Lill-Tove, Donnem, Tom
Publicado 2012

Lymphangiogenic Markers and Their Impact on Nodal Metastasis and Survival in Non-Small Cell Lung Cancer - A Structured Review with Meta-Analysis

por Kilvaer, Thomas K., Paulsen, Erna-Elise, Hald, Sigurd M., Wilsgaard, Tom, Bremnes, Roy M., Busund, Lill-Tove, Donnem, Tom
Publicado 2015

Digitally quantified CD8(+) cells: the best candidate marker for an immune cell score in non-small cell lung cancer?

por Kilvaer, Thomas K, Paulsen, Erna-Elise, Andersen, Sigve, Rakaee, Mehrdad, Bremnes, Roy M, Busund, Lill-Tove Rasmussen, Donnem, Tom
Publicado 2020

Prognostic Impact of Lymphocytes in Soft Tissue Sarcomas

por Sorbye, Sveinung W., Kilvaer, Thomas, Valkov, Andrej, Donnem, Tom, Smeland, Eivind, Al-Shibli, Khalid, Bremnes, Roy M., Busund, Lill-Tove
Publicado 2011

High tumor cell expression of microRNA-21 in node positive non-small cell lung cancer predicts a favorable clinical outcome

por Stenvold, Helge, Donnem, Tom, Andersen, Sigve, Al-Saad, Samer, Valkov, Andrej, Pedersen, Mona Irene, Busund, Lill-Tove, Bremnes, Roy M
Publicado 2014

The impact of MET, IGF-1, IGF1R expression and EGFR mutations on survival of patients with non-small-cell lung cancer

por Al-Saad, Samer, Richardsen, Elin, Kilvaer, Thomas K., Donnem, Tom, Andersen, Sigve, Khanehkenari, Mehrdad, Bremnes, Roy M., Busund, Lill-Tove
Publicado 2017

High miR-205 expression in normal epithelium is associated with biochemical failure - an argument for epithelial crosstalk in prostate cancer?

por Nordby, Yngve, Richardsen, Elin, Ness, Nora, Donnem, Tom, Patel, Hiten R. H., Busund, Lill-Tove, Bremnes, Roy M., Andersen, Sigve
Publicado 2017

Prognostic impact of peritumoral lymphocyte infiltration in soft tissue sarcomas

por Sorbye, Sveinung W, Kilvaer, Thomas K, Valkov, Andrej, Donnem, Tom, Smeland, Eivind, Al-Shibli, Khalid, Bremnes, Roy M, Busund, Lill-Tove
Publicado 2012

Prognostic impact of CD57, CD68, M-CSF, CSF-1R, Ki67 and TGF-beta in soft tissue sarcomas

por Sorbye, Sveinung W, Kilvaer, Thomas K, Valkov, Andrej, Donnem, Tom, Smeland, Eivind, Al-Shibli, Khalid, Bremnes, Roy M, Busund, Lill-Tove
Publicado 2012

Prognostic Impact of Jab1, p16, p21, p62, Ki67 and Skp2 in Soft Tissue Sarcomas

por Sorbye, Sveinung W., Kilvaer, Thomas K., Valkov, Andrej, Donnem, Tom, Smeland, Eivind, Al-Shibli, Khalid, Bremnes, Roy M., Busund, Lill-Tove
Publicado 2012